RELEASE: Moon Surgical Announces the Appointment of Mark Toland as an Independent Member of the Board of Directors

(Information sent by the signatory company).

RELEASE: Moon Surgical Announces the Appointment of Mark Toland as an Independent Member of the Board of Directors

(Information sent by the signatory company)

Moon Surgical, a pioneer in collaborative robotics, today announced the appointment of Mark Toland as an independent member of the board of directors. With more than 25 years of executive leadership experience in the robotics and medical device industry, Toland joins the board of directors as the company works to complete development of its first product and prepare for the commercial launch of the system. robotic teacher

Mark Toland is currently the CEO of MMI, a surgical robotics company developing a platform for microsurgery. Prior to joining MMI, Toland was Chairman and CEO of Corindus, a world leader in endovascular robotics, which was acquired by Siemens Healthineers for $1.1 billion. He was also an independent member of the board of directors of Cardiologs, which was acquired by Philips in late 2021.

"I am delighted to welcome Mark to our expanded team at Moon Surgical," said Anne Osdoit, CEO of Moon Surgical, and partner at Sofinnova Partners' medtech accelerator, MD Start. "His independent and astute mind and his experience in US go-to-market strategy in our industry will be invaluable in helping us achieve our next goals."

Founded in Paris in 2019 by Pr. Brice Gayet and incubated by Sofinnova MD Start, Moon Surgical has demonstrated its prowess in speed and innovation with early, fully functional systems powered by more than thirty surgeons on two continents. and multiple clinical indications.

"Moon's approach to how laparoscopic surgeons should be supported and empowered in the operating room is truly unique and has the potential to make the Maestro System an absolute must-have in every surgical practice," commented Mark Toland. "I am honored to be part of the team that is revolutionizing minimally invasive surgery with adaptive robotics and I look forward to working together to continue its rapid growth."

Small, adaptable, and integrated into existing clinical workflows, Maestro is designed to support surgeons and patients in the 18.8 million soft tissue surgical procedures currently not supported by telerobotic systems each year.

About Moon Surgical

Moon Surgical, based in Paris, France, and San Carlos, California, believes that the future of the operating room is in the hands of the surgeon.

By equipping surgeons with total control, renewed confidence, and technology adaptable to any situation thrown at them, Moon Surgical strives to improve efficiency in operating rooms and provide better surgical care for patients. The minimalist, co-manipulative Maestro robotic system uses tomorrow's technology to deliver these vital skills to surgeons, today.


Contact name: Moon Surgical